21st February 2025: Redcliffe Labs, a leading pan-Indian omnichannel diagnostics service provider, recently celebrated the grand opening of its state-of-the-art diagnostic laboratory in Jamshedpur, Jharkhand. Located at Kasidih New Layout Area, New Baradwari, Sitaramdera Town, Jamshedpur, this facility expands Redcliffe Labs’ footprint in Jharkhand with 2 Advanced Diagnostic Labs and 50+ Collection Centres and marks another step in its commitment to providing high-quality diagnostic services to people across Bharat.

The lab in Jamshedpur is strategically launched to address the growing NCDs in Jharkhand. A recent healthcare study conducted by the Department of Public Health in Jharkhand underscores an alarming trend: 16.3% of the population grapples with diabetes, and over 21% are affected by hypertension.  Redcliffe Labs with its comprehensive testing capacity, including biochemistry, hematology, immunoassays, clinical pathology, hormones, and serology, and the ability to handle 10,000+ samples over a month, will significantly improve the healthcare scenario for the residents of Jamshedpur and the surrounding regions of Golmuri, Sakchi, Agrico, Bistupur, Kadma, Sonari, Telco Colony, Adityapu, Parsnagar, Baridih, Sidhgora, Burmamine, Kandra, Gamharia, and Chhota Govindpur across Jharkhand. Redcliffe Labs provides the convenience of booking the test through its digital channels, i.e., app, website, WhatsApp with home sample collection services, or visiting the lab or collection centers.

The comprehensive test menu of Redcliffe Labs is created to address the diverse healthcare needs of patients across all age groups with advanced diagnostic testing. The sample collection process is carried out in a single prick precisely by a DMLT-certified phlebotomist. Each sample undergoes precise evaluation, with over 50+ stringent internal and external quality checks to deliver accurate, actionable, and easy-to-understand smart reports.  All the reports are evaluated by the MD pathologist before being shared with the patients. All the possible measures are taken to enhance patient outcomes and support clinicians with faster and more reliable reports.

To improve awareness and shift patients’ focus from curative care to preventive care, Redcliffe Labs organizes weekly health camps every Sunday, enhancing patient outreach. Also, everyone across the serviceable region can benefit from the launch offer of getting all the services at an additional 10% discount.

Redcliffe Labs solidifies its position as a leading regional diagnostic service provider by ensuring accessible, affordable, and accurate diagnostics. Dr. Arvind Kumar, Lab Head and Consultant Pathologist with over two decades of experience in analyzing, monitoring, and controlling the quality of lab procedures, will lead the new facility. His experience includes services as HOD & Consultant Pathologist in other renowned labs and hospitals like the Ministry of Health and Quality of Life,  Mauritius, Brahmadanda Narayana  Multispecialty Hospital (a unit of Narayana Health), and more.  Dr Arvind’s expertise and excellence in diagnostics will instill confidence in customers and assure them of the highest standards of care.

Aditya Kandoi, Founder and CEO of Redcliffe Labs, said, “Healthcare is not a privilege—it’s a fundamental necessity.” Our strategically planned lab in Jamshedpur marks a decisive step toward addressing the growing burden of non-communicable diseases (NCDs) by enabling early detection and timely intervention. Equipped with state-of-the-art diagnostics, advanced technology, and stringent quality benchmarks, we are committed to delivering unparalleled accuracy in every test. This initiative will empower clinicians with precise clinical insights for informed decision-making while enabling individuals to take proactive ownership of their well-being.

Non-communicable diseases (NCDs) are silently impacting millions, yet timely diagnosis remains a challenge. At Redcliffe Labs, we are working towards transforming on-ground healthcare across Bharat, one step at a time. By expanding doorstep services, we aim to bridge the gap between early detection and timely intervention—because proactive healthcare isn’t just an option, it’s a necessity.”

Redcliffe Labs Infrastructure, backed by AI and ML, helps create an excellent customer experience. Customers can create profiles, track samples, download smart reports, and get comparative health progress reports. The reports offer a comprehensive analysis of every customer’s health status. Also, Redcliffe Labs is the first to use temperature-monitored technology to ensure sample integrity and stability, providing accurate results.

The post Redcliffe Labs Strengthens Presence in Jharkhand with Second State-of-The-Art Lab, Enhancing Healthcare Accessibility through Quality Diagnostics appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

New Delhi, India – 14 November 2024 – With India now labeled as the diabetes capital of the world, Redcliffe Labs is taking a tech-forward approach to help combat the surging numbers, particularly among younger demographics. On World Diabetes Day, the company launched a digital ‘Prediabetes Risk Checker’ tool on its official Android app. This tool launch is part of Redcliffe Labs’ larger awareness campaign, “Beat the Sugar Trap,” which emphasizes the critical health risks associated with diabetes and educates on prevention strategies to promote better long-term health.

Using data analytics and interactive technology, the Prediabetes Risk Checker is a quick digital assessment designed to give users an instant snapshot of their diabetes risk by evaluating responses to lifestyle and genetic questions. This technology enables individuals, particularly in urban areas with higher incidence rates, to gauge their risk easily without formal consultation. It is more relevant today when over 136 million people are living with prediabetes.

Beyond raising awareness, this technology-driven solution empowers users by providing them with actionable insights. Based on their risk score, users receive personalized recommendations to modify their lifestyle and are encouraged to undertake diagnostic tests for informed decision-making. By providing a clear roadmap to better health, Redcliffe Labs encourages Indians to prioritize preventive care instead of reactive treatments.

“Diabetes is no longer an age-specific concern—it’s affecting younger people in greater numbers, making early detection and prevention essential. Reversing prediabetes is the key to fighting all the associated health risks, which can range from weakening your immunity system to increasing the heart risk to double,” says Aditya Kandoi, CEO & Founder of Redcliffe Labs. “Our Prediabetes Risk Checker provides a user-friendly, tech-based solution that not only helps individuals understand their risk factors but also guides them on taking further steps to mitigate those risks before diabetes develops.”

Through the Beat the Sugar Trap campaign, Redcliffe Labs aims to counter the alarming trend of diabetes among India’s youth.

Dr. Geetanjali Gupta, Director of Technical Operations and Quality Assurance at Redcliffe Labs, said, “We at Redcliffe Labs regularly perform over 50 stringent quality checks to deliver accurate and reliable health check reports for informed decision-making. However, to reach the masses, technology plays a crucial role. It enables us to make preventive healthcare more accessible and personalized. Our Prediabetes Risk Checker represents our commitment to supporting India’s fight against diabetes by empowering individuals to make informed, timely health decisions.”

The Prediabetes Risk Checker aligns with Redcliffe Labs’ purpose of Giving India its Right to Quality Diagnostics, which is possible through Awareness, Accessibility, Affordability, and Accuracy. 

By harnessing digital tools, Redcliffe Labs enhances accessibility, enabling people across 220+ cities to monitor their health easily. This tech-driven approach ensures that healthcare reaches even those in remote areas, bridging the gap and making preventive care achievable. 

The post World Diabetes Day: Redcliffe Labs Launches Digital Prediabetes Risk Checker Tool for Early Diagnosis  appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

21 October 2024: Redcliffe Labs, a purpose-driven PAN India omnichannel diagnostics service provider, has expanded its footprint in Gujarat with two more state-of-the-art diagnostic laboratories in Surat and Vadodara. The company now operates with a network of 3 laboratories and 30 collection centers across the state, and the latest expansion reinforces Redcliffe’s commitment to Giving India its Right to Quality Diagnostics.

Aligned with Redcliffe Labs’ strategic goal to extend its reach into Tier II and Tier III cities and beyond, this expansion ensures that accurate and reliable diagnostic services are not restricted to metropolitan regions but accessible to communities across the entire geography of Bharat. These advanced facilities are well-equipped with the latest diagnostic technology, enabling accurate reports within the minimum possible turnaround time. This development underlines Redcliffe Labs’ dedication to enhancing healthcare accessibility, considering the increasing demand for reliable and timely diagnostic services.

Redcliffe Labs offers over 3,600 routine and specialized tests, covering a broad spectrum of diagnostic categories such as advanced pathology, biochemistry, hematology, immunoassays, histopathology, clinical pathology, cytopathology, molecular/genomic testing, hormones, microbiology, and infectious disease serology.

Each laboratory is strategically located to service the city’s population and nearby areas, ensuring a balance of convenience and reliability. The Vadodara lab, situated near Samruddhi Trade Centre in Kendranagar, will be operating under the leadership of seasoned consultant pathologist Shah Jigar Kiritkumar, with over 12 years of experience offering quicker access to diagnostic services for nearby communities, including Pal Gam, Adajan, Vesu, Hazira, Gopi Talav, Utran, Bardoli, Palsana, Kamrej, and Ichchhpur.  In Surat, the lab will be managed by Tejal Keyur Bhatt, Zonal Laboratory Head – West, who brings over eight years of industry expertise. Located at the Zenon Complex near Unique Hospital, it will efficiently serve residents surrounding Surat’s Ring Road, Alkapuri, Bhayli, Manjalpur, Karelibaug, Gorwa, Vemali, Sardar Nagar, Akota, Harni, and Tarsali. 

Dr. Geetanjali Gupta, Director-Technical Operations and Quality Assurance at Redcliffe Labs, said, “The opening of our two advanced diagnostic centers in Surat and Vadodara marks a key milestone in our journey to make high-quality diagnostic services accessible to everyone, surpassing all geographical limitations. We aim to provide timely, accurate, and reliable diagnostics to individuals in every corner of the country to drive better health outcomes across Bharat. We’re enhancing healthcare services in these regions by embracing cutting-edge technology, upholding strict quality standards, and focusing on a patient-first approach; our mission has always been to ensure that no geographical boundaries limit access to quality care.”

Redcliffe Labs maintains exceptional quality standards by strictly following NABL and ISO protocols, utilizing six-sigma methodologies, and performing more than 50 regular stringent quality checks across its diagnostic network. The company impressively leverages AI and ML-powered systems to elevate the customer experience, offering advanced features such as real-time sample tracking and easy smart report downloads. It also provides comparative health progress reports, ensuring accuracy and reliability. Furthermore, Redcliffe Labs’ temperature-controlled technology safeguards sample integrity, whether patients visit the lab in person or opt for the convenience of home sample collection through the app, website, or WhatsApp.

The post Redcliffe Labs Expands its Network in Gujarat, Brings Quality Diagnostics to Surat and Vadodara appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

17, September, 2024: Redcliffe Labs, a leading PAN-India omnichannel diagnostics service provider, has successfully raised USD 42 million in Series C funding. IFU (Investeringsfonden for Udviklingslande), Denmark’s Investment Fund for Developing Countries, is leading the funding round with USD 20 million, followed by existing investor LeapFrog Investments with USD 15 million. The remaining capital has been committed by existing shareholders HealthQuad and Spark Growth Ventures. This fresh injection of capital will fuel Redcliffe’s expansion plans, focusing on deepening its presence in Tier II and III cities across India.

Redcliffe is committed to delivering quality diagnostics to India and will use the funds to open more labs and collection centres along with an expansion of its home collection network. The company has successfully executed strategic acquisitions in North-Western India and continues to pursue a PAN-India expansion through strategic partnerships and further acquisitions. It is currently in advanced discussions with potential partner diagnostic chains to deepen the accessibility of quality diagnostics across India & further its market share.

The funding comes as Redcliffe makes key additions to its board and management, which are aligned with its commitment to improving governance and driving profitable growth. Ankur Shah has joined as an Independent Director, bringing 27 years of experience, including his role as Chief Finance & Strategy Officer of Careem, which was acquired by Uber. Additionally, Alka Saxena has been appointed as CFO, bringing 24 years of finance experience, including 17 years of experience working with Healthcare companies including Health Care At Home (HCAH) and Dr. Lal Path Labs in various leadership roles as CFO, Head of Finance, Controls & Assurance.

Aditya Kandoi, Founder & CEO, Redcliffe Labs, said, “Our aim is to democratise access to high-quality, affordable, accurate diagnostics for every Indian, with a particular focus on the underserved populations in Tier II and III cities. This funding round is not just a financial milestone; it’s a catalyst for transformative change in India’s healthcare landscape. With this raise, we’re poised to increase accessibility to advanced diagnostic services across the nation with a commitment to empower individuals with the knowledge and tools they need to take charge of their health. By bringing cutting-edge diagnostics to the doorsteps of millions, we’re nurturing a healthier Bharat.”

Emil Sierczynski, Investment Director & Co-lead for India health investments, IFU, stated, “We view healthcare as more than just an investment sector – it’s a fundamental pillar in our strategy to drive meaningful social impact. Redcliffe’s innovative approach to diagnostics has the potential to touch millions of lives, bringing essential health services to previously underserved communities. This aligns perfectly with our mission to support businesses that create lasting positive change. We’re not just investing in a company; we’re investing in a healthier, more equitable future for India. The ripple effects of improved healthcare access can be profound – from increased productivity to stronger communities – and we’re excited to be part of this journey with Redcliffe Labs.”

Biju Mohandas, Partner and Global Co-Lead for Health Investments, LeapFrog Investments, commented, “We are delighted to have helped catalyse Redcliffe Lab’s Series C round, bringing the company to the next stage of growth. The Indian healthcare industry, particularly the diagnostics sector, is at an inflection point, presenting growth opportunities. Redcliffe Labs stands out in this landscape for its impressive growth trajectory and its commitment to customer-centricity and quality. Their NABL accreditation and adherence to Six Sigma practices showcase their dedication to excellence, creating a significant impact for millions of patients. Redcliffe’s rapid progress also underscores the drive, resilience and quality of their team. Our continued investment in Redcliffe Labs aligns perfectly with LeapFrog’s mission to support businesses that drive both financial returns and measurable social impact. We believe Redcliffe’s model has the potential to be a blueprint for accessible, high-quality healthcare services across the country.”

Since its inception in 2018, Redcliffe Labs has rapidly grown to become one of India’s leading omnichannel diagnostics chains. The company currently owns and operates more than 80+ state-of-the-art labs, processing tests from 2,000+ collection centres & home collection services powered by 1,000+ phlebotomists across 220+ cities in India. In 2022, Redcliffe Labs completed its Series B fundraising and has since achieved remarkable growth and expanded its diagnostic network significantly. The new Series C funding round further accelerates its purpose to give India its right to quality diagnostics and drive continued innovation across India.

The post Redcliffe Labs Raises USD 42 Million in to StrengSeries C Fundingthen Pan-India Diagnostic Network appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

• The lab will provide high-quality diagnostic services with over 3600+ routine and specialized tests, offering the convenience of home sample collection and walk-in services, ensuring 100% customer convenience.
• This lab in Prayagraj enhances Redcliffe Labs’ presence in Uttar Pradesh, with over 22 laboratories and 500+ collection centers, furthering its purpose of giving India its right to quality diagnostics.

 29 July 2024: Redcliffe Labs, a leading PAN India omnichannel diagnostics service provider, recently celebrated the grand opening of its state-of-the-art diagnostic laboratory in Prayagraj. Located at Lowther Road in George Town, this new facility expands Redcliffe Labs’ footprint in Uttar Pradesh. It marks another step in its commitment to providing high-quality diagnostic services to people across Bharat.

The lab in Prayagraj, with its comprehensive testing capacity, including biochemistry, hematology, immunoassays, clinical pathology, hormones, and serology, and the ability to handle 10,000+ samples over a month, will significantly improve the healthcare accessibility for the residents of Prayagraj and the surrounding regions of Kaushambi Handia, Pratapgarh, Mirzapur, and Naini. Redcliffe Labs provides the convenience of booking the test through its digital channels, i.e., app, website, WhatsApp with home sample collection services, or visiting the lab or collection centers.

It ensures access to a comprehensive test menu to address the diverse healthcare needs of patients across all age groups with advanced diagnostic testing. This will enhance patient outcomes and support clinicians with faster and more reliable reports. The lab will also provide training and support to local healthcare professionals, further strengthening the local healthcare ecosystem.

To improve awareness and shift patients’ focus from curative care to preventive care, Redcliffe Labs organizes weekly health camps every Sunday, enhancing patient outreach. Also, everyone across the serviceable region can benefit from the launch offer of getting all the services at an additional 10% discount until August 15th.

With the addition of the NABL and ISO-compliant lab in Prayagraj, Redcliffe Labs solidifies its position as a leading diagnostic service provider in the region. Dr. Ravi Rani, M, D Pathologist, will lead the new facility. His expertise and excellence in diagnostics will instill confidence in customers, assuring them of the highest standards of care.

Dr Geetanjali Gupta, Director- Technical Operations & Quality Assurance, said, ” At Redcliffe Labs, we’re committed to revolutionizing healthcare accessibility nationwide, and this lab in Prayagraj is a testament to the same. Our new state-of-the-art lab setup embodies this vision, offering high-end diagnostics at affordable prices. We are happy to introduce cutting-edge technology and precise diagnostic services with reports as per NABL & ISO guidelines, empowering clinicians to plan personalized treatment and enhancing patient outcomes.

 Redcliffe Labs Infrastructure, backed by AI and ML, helps create an excellent customer experience. Customers can create profiles, track samples, download smart reports, and get comparative health progress reports. The reports offer a comprehensive analysis of every customer’s health status. Also, Redcliffe Labs is the first to use temperature-monitored technology to ensure sample integrity and stability, ensuring accurate results.

The post Redcliffe Labs sets up a lab in Prayagraj, Enhancing Healthcare Accessibility through Quality Diagnostics. appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

India, February 05th, 2024:  In a dedicated effort to champion women’s health, Redcliffe Labs, a leading omnichannel diagnostics provider in India, launched a need-of-the-hour wellness campaign, ‘Be Your Own Sheroes- Learn, Prevent, Screen’ during Cervical Cancer Month. The month-long campaign, initiated in January 2024, was committed to illuminating the importance of early detection and preventive measures against cervical cancer. The initiative was conducted on a pan-Indian scale and strives to empower women to manage their health proactively. It aimed to build a healthier and more informed Bharat, where each woman is the hero of her health and well-being. The campaign has reached over 5 Million people in 220+  cities across India with over 75% engagement rate, creating a long-lasting impact on the importance of early detection and preventive measures against cervical cancer.

In the last week of October 2023, when more than 35 senior doctors and researchers were present, there was a significant discussion on the rising health concern in India- Cervical Cancer as the number of cases increased. Every year, over 123907 women are diagnosed with cervical cancer, and for 77348, it proves to be fatal. In India, cervical cancer is the second leading cause of cancer deaths among women.The country accounts for 25% of deaths across the globe due to cervical cancer, primarily due to a lack of effective screening and access to timely treatment. January is globally dedicated to raising cervical cancer awareness, and Redcliffe Labs took the initiative to amplify awareness in India.

The campaign was designed to equip women with knowledge about the risk factors, symptoms, and screening options like HPV and pap smear tests available for cervical cancer, fostering a proactive approach to their well-being. Moreover, getting health checkups for cervical cancer is very feasible and cost-effective as it is required once in three years.  Also, Finance Minister Nirmala Sitharaman on February 1 announced the government’s plans to focus on vaccination against cervical cancer for girls aged 9 to 14 as part of her Interim Budget 2024.

Dr Sohini Sengupta, Medical Laboratory Director at Redcliffe Labs, says, “Since 88% of working women in India are not vaccinated against cervical cancer, the need for our ‘Be Your Own Sheroes’ campaign becomes even more evident. Also, the survival rate in stage I cervical cancer can increase by up to 90% with a timely diagnosis and the right treatment at the right time. This highlights the profound impact of early detection and preventive measures. Our mission with the campaign is to increase awareness among women about the importance of regular screenings and vaccinations, empowering them to take proactive steps in their health journey. By doing so, we aim to foster a future where cervical cancer is not only treatable but preventable, creating a healthier and more informed Bharat.”

As  part of the campaign, Redcliffe Labs actively engaged with individuals to raise awareness among women about the importance of regular screenings and vaccinations for prevention. A combination of online campaigns across social media channels and on-the-ground health camps is being implemented. They have been conducting webinars and live sessions with experienced oncologists and gynecologists across digital media platforms, as well as hosting offline awareness camps across India. Through the campaign, Redcliffe Labs successfully bridged the information gap, ensuring that women are equipped with the knowledge to make informed decisions about their health and continue to do so for a Healthier Bharat.

The post Redcliffe Labs’ first campaign for Cervical Cancer Prevention Awareness, ‘Be Your Own Sheroes- Learn, Prevent, Screen’, reaches over 5 Million people in 220+ Cities PAN India appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

India, January 16, 2024: Redcliffe Labs, a Pan India omnichannel diagnostics provider, substantially improves lab quality processes by embracing Six Sigma metrics. In a study led by Dr. Sohini Sengupta, Medical Laboratory Director at Redcliffe Labs, her team of experts assessed testing processes to optimize the laboratory’s quality control practices. It translates to fewer errors, fewer sample reruns, and improved turnaround times, bolstering clinician reliance and patient satisfaction.

Redcliffe Labs conducted a two-phase quality improvement project with a comprehensive assessment of sigma scores across 25 routine high-volume assay parameters, encompassing 20 clinical chemistry and 5 immunoassay methods. By identifying the parameters with lower sigma scores in the initial phase, i.e., pre-period, they successfully implemented strategic measures to enhance their analytical quality within a rigorous 6-month timeframe. The analysis was performed on the Alinity ci series equipment from Abbott.

After the targeted improvements, the team at Redcliffe Labs conducted the post-period analysis to gauge the tangible and positive impact. It included a thorough evaluation of sigma metrics to measure any enhancements in the laboratory’s performance. The average sigma surged significantly from 6.4σ to an impressive 9.2σ. Out of the 25 analytes studied, a substantial 17 exhibited a noteworthy improvement, surpassing the pre-defined threshold of a 1.0 increase in their sigma metric.

One of the most notable advancements was observed in Glucose(most commonly tested parameter) showcasing an extraordinary surge from 3.9σ to an exceptional 26.3σ. The increase in the sigma metric for glucose directly correlates to a substantial reduction in the error rate, estimated from 9,224 Defects Per Million Opportunities (DPMO) to less than 1 DPMO, significantly enhancing the reliability of test results.

Dr. Sohini Sengupta, Medical Laboratory Director at Redcliffe Labs, said, “The impact of our quality improvement study extends far beyond metrics—it’s a testament to our commitment to excellence. Achieving world-class performance across high-volume assays by adopting Sigma metrics elevates our confidence in our test results. It reiterates our continued focus on achieving the highest standards of quality at Redcliffe. These enhancements also mean fewer errors, efficient workflows, and faster turnaround times.”

The post Redcliffe Labs bolsters lab processes through Six Sigma metrics appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

• This recognition underscores the company’s success in seamlessly integrating advanced technology, cost-efficiency, and convenience in healthcare diagnostics.

India , December 26th, 2023: Redcliffe Labs, a Pan India omnichannel diagnostics service provider, secures a coveted position in the esteemed Deloitte Technology Fast 50 India 2023, a testament to its rapid growth as a leading omnichannel diagnostics provider. This recognition reflects Redcliffe Labs’ dedication to making high-quality diagnostics accessible, affordable, and convenient nationwide for a Healthier Bharat.

In a relatively short duration, Redcliffe Labs has rapidly expanded its extensive network, boasting 80+ state-of-the-art owned labs and 2000+ collection centers across 220+ cities in India. Leveraging innovative diagnostic solutions, the company ensures unparalleled services and patient experiences with home sample collection, maintaining the highest quality standards in Bharat, including Tier 2 & Tier 3 cities. With over 100% revenue growth in the past two years, Redcliffe Labs continues its commitment to advancing healthcare accessibility and quality.

Dheeraj Jain, Founder of Redcliffe Labs, said, “At Redcliffe Labs, we’re at the forefront of leveraging innovation and technology to redefine healthcare accessibility. Our commitment to affordable, accessible, and convenient diagnostics has driven our exceptional growth. Being recognized in the Deloitte Technology Fast 5 not only reflects financial success but also validates our dedication to enhancing healthcare outcomes in Indian communities. As one of the top five fastest-growing technology companies, we are honored. Our focus on staying ahead in technology and innovation ensures improved customer experiences, supports clinicians, and contributes significantly to the industry’s advancement.”

Securing a position among the top five companies in the Deloitte Technology Fast 50 India ranking underscores Redcliffe Labs’ unwavering commitment to technology. Through its impactful contributions to the healthcare industry, Redcliffe Labs has demonstrated visionary leadership, determination, and adaptability in a rapidly evolving landscape,” commented Peeyush Vaish, Partner and TMT Industry Leader, Deloitte Touche Tohmatsu India LLP.

The Deloitte India Tech Fast 50 Programme, launched in 2005, honors the most innovative and fastest-growing public and private companies from all over India. The awards programme was created to recognize the passion and dedication it takes to be an industry disrupter using technology. Rankings are based on percentage revenue growth over three years. Redcliffe Lab’s inclusion among the top five companies underpins its growth, innovation, and impact in the healthcare diagnostic sector.

About Deloitte Technology Fast 50 India programme selection and qualifications

The Deloitte Technology Fast 50 India programme, which was launched in 2005, is conducted by Deloitte Touche Tohmatsu India LLP (DTI LLP) and is part of a truly integrated Asia Pacific programme recognising India’s fastest growing and most dynamic technology businesses (public and private) and includes all areas of technology – from internet to biotechnology, from medical and scientific to computers/hardware.

The programme recognises the fastest-growing technology companies in India based on their percentage revenue growth over the past three financial years.

The post Redcliffe Labs ranked among the Top 5 fastest growing Tech Companies in the Esteemed 18th Edition of Deloitte Technology Fast 50 India 2023 appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

India, 23, November, 2023: Redcliffe Labs, a Pan India omnichannel diagnostics provider, has opened three new state-of-the-art diagnostic labs in Uttar Pradesh. Strategically located in Prayagraj, Agra, and Jhansi, these facilities aim to bridge the significant gap between the demand and supply of quality diagnostic services in the region.

Uttar Pradesh, the country’s most populous state with a population of 240 million (16.5% of the overall population), is facing a 19% increase in the burden of Non-Communicable Diseases (NCDs). Recognizing the urgent need to address this health challenge, Redcliffe Labs has expanded its presence in UP as part of its mission to implement a tier 2 and beyond strategy. They aim to make Bharat healthier by reaching both grassroots and high-end segments, ensuring that quality diagnostic services are affordable, accessible, and convenient.

Redcliffe Labs distinguishes itself through the seamless integration of cutting-edge technology in its services. Beyond catering to the local community, individuals in surrounding areas can conveniently access state-of-the-art facilities by scheduling home sample collections for their health checkups. Moreover, the collected samples are transported in temperature-controlled bags to safeguard their integrity and provide precise reports to the patients.

The newly opened labs in Prayagraj, Agra, and Jhansi will offer a comprehensive range of diagnostic services, including Biochemistry, Hematology, Immunoassays, Clinical Pathology, Serology, and Hormones. Patients can avail of these services through home sample collection and walk-ins at collection centers, providing flexibility and convenience.

With 21+ labs and 500+ collection centers across Uttar Pradesh, Redcliffe Labs continues to lead in diagnostic healthcare services. MD Pathologist Dr. Ravi Rani will head the Prayagraj facility in George Town. With a new lab at Shanti Madhuban Plaza, Agra will also benefit from Redcliffe Labs’ presence. Consultant Pathologist Dr. Priya Jain will oversee this lab. In Jhansi, the state-of-the-art laboratory in Veerangna Nagar, JDA Colony, will be led by Consultant Pathologist Dr. Tripti Aggarwal, marking a significant advancement in healthcare services.

 All the MD Pathologists at Redcliffe Labs have over 5+ years of experience and use their expertise to ensure six-sigma processes for analyzing a sample and delivering the most accurate reports as per NABL & ISO guidelines.

Commenting on the expansion, Dr. Sohini Sengupta, Medical Laboratory Director, Redcliffe Labs, stated, “As we venture into the heart of Uttar Pradesh, a dynamic state pulsating with vitality and home to millions, our dedicated healthcare professionals reaffirm their unwavering commitment to improving lives, transcending geographical boundaries. Uttar Pradesh represents a diverse tapestry of health needs, and Redcliffe Labs, propelled by cutting-edge technology, cost-effectiveness, and steadfast accessibility, endeavors to bring high-quality healthcare within reach of every individual. In undertaking this journey, our objective extends beyond diagnostics; we aim to serve as a cornerstone of health and wellness, strategically addressing challenges and contributing to a substantive enhancement of the healthcare landscape.”

Redcliffe Labs steadfastly upholds its mission to extend its presence to every corner of the nation, unwaveringly progressing towards fostering a Healthier Bharat.

The post Redcliffe Labs expands diagnostic services in Uttar Pradesh, focusing on underserved Tier 2, 3, and 4 cities appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

India, October 31st, 2023: Redcliffe Labs, one of India’s fastest-growing omnichannel diagnostics service providers, expanded its services with the addition of Prostate Health Index (PHI) test processing at its National Reference Laboratory located in Noida. The blood test may be included in the standard urologic armamentarium for biopsy decisions, risk stratification, and treatment selection for suspected prostate cancer. This pioneering advancement in diagnostic capabilities is set to revolutionise prostate cancer screening and diagnosis, benefiting patients across India.

The incidence of prostate cancer has increased steadily in India over the years. According to data from the National Centre for Disease Informatics and Research (NCDIR), it is among the top 10 cancers in urban cancer registries of Bangalore, Delhi, Bhopal, and Mumbai. Recognizing the growing concern surrounding prostate cancer, Redcliffe Labs is introducing PHI testing as part of a multifaceted approach to screening.

The PHI test is a simple and cost-effective blood test that plays a crucial role in identifying patients who genuinely require a prostate biopsy, ultimately reducing the occurrence of negative biopsies. It combines serum total PSA, free PSA (fPSA), and p2PSA ([-2]proPSA) concentrations through a mathematical formula that enhances clinical sensitivity and specificity for prostate cancer risk assessment. This test will benefit men aged 50 and above with non-suspicious digital rectal examination (DRE) results and a total prostate-specific antigen (PSA) range of 4 to 10 ng/mL.

Redcliffe Labs will provide same-day results for PHI tests, offering quick and efficient access to vital diagnostic information.

Dr. Sohini Sengupta, Medical Laboratory Director at Redcliffe Labs, highlights the urgency of addressing the increasing prostate cancer cases in India. To combat this challenge, Redcliffe Labs introduces the advanced PHI test, surpassing the PSA test in accuracy up to three times. This advanced test not only enhances healthcare accuracy but also empowers individuals and clinicians for informed decision-making.

With the inclusion of this unparalleled processing at Redcliffe’s National Reference Lab, the PHI test is now accessible to a wider audience. Redcliffe Labs remains dedicated to empowering individuals through preventive health checkups and education, fostering a healthier society.

The post Redcliffe Labs Introduces Advanced PHI processing capability at its National Reference Lab, Noida appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.